Correlation Between Insight Molecular and Codexis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Insight Molecular and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Insight Molecular and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Insight Molecular Diagnostics and Codexis, you can compare the effects of market volatilities on Insight Molecular and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Insight Molecular with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Insight Molecular and Codexis.

Diversification Opportunities for Insight Molecular and Codexis

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Insight and Codexis is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Insight Molecular Diagnostics and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Insight Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Insight Molecular Diagnostics are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Insight Molecular i.e., Insight Molecular and Codexis go up and down completely randomly.

Pair Corralation between Insight Molecular and Codexis

Given the investment horizon of 90 days Insight Molecular Diagnostics is expected to generate 1.27 times more return on investment than Codexis. However, Insight Molecular is 1.27 times more volatile than Codexis. It trades about 0.27 of its potential returns per unit of risk. Codexis is currently generating about -0.17 per unit of risk. If you would invest  249.00  in Insight Molecular Diagnostics on August 24, 2025 and sell it today you would earn a total of  355.00  from holding Insight Molecular Diagnostics or generate 142.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Insight Molecular Diagnostics  vs.  Codexis

 Performance 
       Timeline  
Insight Molecular 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Insight Molecular Diagnostics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Insight Molecular showed solid returns over the last few months and may actually be approaching a breakup point.
Codexis 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Insight Molecular and Codexis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Insight Molecular and Codexis

The main advantage of trading using opposite Insight Molecular and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Insight Molecular position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.
The idea behind Insight Molecular Diagnostics and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope